• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to the comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions".

作者信息

Varma Manthena V S, Lai Yurong, Feng Bo, Litchfield John, Goosen Theunis C, Bergman Arthur

出版信息

Pharm Res. 2013 Jun;30(6):1469-70. doi: 10.1007/s11095-013-0987-6. Epub 2013 Mar 6.

DOI:10.1007/s11095-013-0987-6
PMID:23462935
Abstract
摘要

相似文献

1
Response to the comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions".对文章《基于生理学的普伐他汀转运体介导的肝胆处置及药物-药物相互作用建模》评论的回应
Pharm Res. 2013 Jun;30(6):1469-70. doi: 10.1007/s11095-013-0987-6. Epub 2013 Mar 6.
2
Comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions".
Pharm Res. 2013 Jun;30(6):1467-8. doi: 10.1007/s11095-013-0988-5. Epub 2013 Mar 16.
3
Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions.基于生理学的普伐他汀转运体介导的肝胆处置和药物相互作用的建模。
Pharm Res. 2012 Oct;29(10):2860-73. doi: 10.1007/s11095-012-0792-7. Epub 2012 May 26.
4
Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans.基于生理的药代动力学建模以预测普伐他汀在人体内由转运体介导的清除率和分布情况。
J Pharmacol Exp Ther. 2009 Feb;328(2):652-62. doi: 10.1124/jpet.108.146647. Epub 2008 Nov 10.
5
Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling.利用可平板培养的人源肝细胞和人血浆数据以及 PBPK 模型预测普伐他汀作为 OATP 底物的药代动力学。
CPT Pharmacometrics Syst Pharmacol. 2018 Apr;7(4):251-258. doi: 10.1002/psp4.12283. Epub 2018 Feb 13.
6
Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes.人类肝脏特异性有机阴离子转运体LST-1介导普伐他汀被人肝细胞摄取。
J Pharmacol Exp Ther. 2001 Jun;297(3):861-7.
7
The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.肝脏转运和代谢在普伐他汀或瑞格列奈与两种大鼠 rOatp 抑制剂相互作用中的作用。
Eur J Pharm Sci. 2013 Jul 16;49(4):767-72. doi: 10.1016/j.ejps.2013.04.030. Epub 2013 May 3.
8
[Effect of pravastatin on transportation of scutellarin in mouse liver and its mechanism].[普伐他汀对灯盏花素在小鼠肝脏中转运的影响及其机制]
Yao Xue Xue Bao. 2011 Mar;46(3):269-73.
9
Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.贴壁培养的大鼠和人肝细胞对转运体底物摄取的文化期依赖性变化。
Drug Metab Dispos. 2011 Sep;39(9):1503-10. doi: 10.1124/dmd.111.038968. Epub 2011 Jun 14.
10
Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.高胆固醇饮食对普伐他汀在灌注大鼠肝脏中处置的影响。
Eur J Drug Metab Pharmacokinet. 2017 Jun;42(3):519-526. doi: 10.1007/s13318-016-0367-9.

本文引用的文献

1
Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide.机制建模预测瑞格列奈的转运体和酶介导的药物相互作用。
Pharm Res. 2013 Apr;30(4):1188-99. doi: 10.1007/s11095-012-0956-5. Epub 2013 Jan 10.
2
Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes.有机阴离子转运多肽 (OATP) 的表达特征及其对人肝细胞摄取底物的功能贡献。
Mol Pharm. 2012 Dec 3;9(12):3535-42. doi: 10.1021/mp300379q. Epub 2012 Nov 2.
3
Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions.
基于生理学的普伐他汀转运体介导的肝胆处置和药物相互作用的建模。
Pharm Res. 2012 Oct;29(10):2860-73. doi: 10.1007/s11095-012-0792-7. Epub 2012 May 26.
4
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.基于人肝 sandwich 培养物肝细胞数据的转运体介导处置的机制药代动力学建模以用于在人体中的预测。
Drug Metab Dispos. 2012 May;40(5):1007-17. doi: 10.1124/dmd.111.042994. Epub 2012 Feb 16.
5
Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters.通过绝对定量肝内外排转运体来提高体外三明治培养大鼠肝细胞肝清除率的推断。
Mol Pharm. 2010 Jun 7;7(3):630-41. doi: 10.1021/mp9001574.
6
The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling.通过基于生理的药代动力学模型对细胞色素P450介导的药物相互作用进行定量预测。
Pharm Res. 2008 Aug;25(8):1891-901. doi: 10.1007/s11095-008-9607-2. Epub 2008 May 16.
7
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.居住在同一环境中的白种人和亚洲受试者中瑞舒伐他汀的药代动力学和药物遗传学。
Clin Pharmacol Ther. 2005 Oct;78(4):330-41. doi: 10.1016/j.clpt.2005.06.013.